HYBRID EVENT: You can participate in person at Boston, Massachusetts, USA or Virtually from your home or work.

8th Edition of International Conference on Neurology and Brain Disorders

October 19-21, 2023

October 19 -21, 2023 | Boston, Massachusetts, USA

Exhibitor

STORZ MEDICAL AG, founded in 1987, is an independent partner company of the KARL STORZ Group. We are a medical technology manufacturer located in the heart of Europe, on the Swiss shore of Lake Constance in Tägerwilen, and we develop innovative shock wave systems and shock wave devices of the highest precision.

As a reliable partner to physicians, we are shaping a piece of medical progress – in the service of new therapeutic procedures. The goal of our physicists and engineers is to further develop shock wave technology, to develop new device concepts and to open up new indications in close cooperation with leading medical institutes.

Unique pioneering achievements, such as the invention of the electromagnetic cylindrical source or the first use of shock waves for cardiac revascularisation, as well as combined shock wave therapy (focused and radial) for pathological changes in tendons, ligaments, capsules, muscles and bones, represent STORZ MEDICAL’s broad range of services in the field of shock wave therapy.

As early as the mid-1990s, STORZ MEDICAL recognised the effectiveness of shock waves for peripheral neurological diseases such as spastic movement disorders. The first treatments of patients with Alzheimer’s dementia have been carried out since 2015, in close cooperation with clinical partners in Germany and Austria.

With Transcranial Pulse Stimulation (TPS®), STORZ MEDICAL offers a therapy option for mild and moderate Alzheimer’s dementia that has been approved in Europe since 2018. The goal of TPS® is to improve or maintain the cognitive abilities of people with Alzheimer’s dementia through non-invasive focal brain stimulation.

With Extracorporeal Magnetotransduction Therapy (EMTT®), STORZ MEDICAL is launching a new non-invasive procedure in 2020 for the treatment of chronic musculoskeletal disorders, which are the most common cause of (chronic) pain worldwide. These disorders include back pain and osteoarthritis as well as typical sports injuries such as inflammation of the tendons and joints.

Watsapp